ARTICLE | Clinical News
Sunvepra asunaprevir: Phase III data
February 29, 2016 8:00 AM UTC
Top-line data from an open-label, Asian Phase III trial in 159 patients with chronic HCV genotype 1b infection who were intolerant or ineligible for interferon (IFN) therapies showed that once-daily 6...